A chondroitinase-ABC and TGF-β1 treatment regimen for enhancing the mechanical properties of tissue-engineered fibrocartilage.
about
Initiation of Chondrocyte Self-Assembly Requires an Intact Cytoskeletal Network.Time and dose-dependent effects of chondroitinase ABC on growth of engineered cartilage.Developing functional musculoskeletal tissues through hypoxia and lysyl oxidase-induced collagen cross-linkingGene signature of the embryonic meniscus.Harnessing biomechanics to develop cartilage regeneration strategies.Engineering a fibrocartilage spectrum through modulation of aggregate redifferentiation.A copper sulfate and hydroxylysine treatment regimen for enhancing collagen cross-linking and biomechanical properties in engineered neocartilage.Engineering functional anisotropy in fibrocartilage neotissues.A review of in-vitro fibrocartilage tissue engineered therapies with a focus on the temporomandibular joint.Application of Extrusion-Based Hydrogel Bioprinting for Cartilage Tissue EngineeringRecent Tissue Engineering Advances for the Treatment of Temporomandibular Joint Disorders.Critical seeding density improves the properties and translatability of self-assembling anatomically shaped knee menisci.Building an anisotropic meniscus with zonal variations.Combined use of chondroitinase-ABC, TGF-β1, and collagen crosslinking agent lysyl oxidase to engineer functional neotissues for fibrocartilage repair.Passive strain-induced matrix synthesis and organization in shape-specific, cartilaginous neotissues.Next Generation Tissue Engineering of Orthopedic Soft Tissue-to-Bone Interfaces.Biochemical Stimulus-Based Strategies for Meniscus Tissue Engineering and Regeneration.Advanced Regenerative Strategies for Human Knee Meniscus
P2860
Q30724351-7C939445-50E0-4AC7-B959-7BF1C028113DQ33895771-7C113AE1-F1B5-4858-9B48-BFD4F93E478FQ34526207-2368244E-259F-43B5-81BA-D62EFD736329Q35012865-F5D335B2-02CA-4F62-8318-AF0CC6E6BE50Q35062155-1D523AEE-B7DB-4163-9D10-3988EFCBB059Q35091513-BD9C5FB1-F507-40A4-92C0-0121D5FF3907Q36860248-CD0CF0AA-5980-4D62-8BED-7778015A5C19Q37451688-8FDD59E0-BB18-4CDB-82CD-C8FF26B84226Q38645472-6C8C2E0F-1296-467D-8626-19CE616A6DD2Q38652777-877326AA-0D32-4BE9-8D3F-3D8A9B1F68DEQ38972524-E0C33C10-48B2-4F7F-A5B1-6BB30CCE41B1Q39126898-61C3F3F6-A3F5-4108-9FAB-56E455FDB991Q41892247-3DD3D71E-C292-4CBC-9B98-2D61C39DB7CFQ42034502-4251AC9F-902A-4CDC-B68B-149C4D37DCBBQ42551647-BDD9DE1D-CA3E-4775-B441-086223162D42Q50049707-6AE77F0C-9F54-48DB-813E-EC9B71EBA86FQ52629074-70DE4F1B-D69D-4083-B42A-697BA2D8306AQ57541667-009A0F19-FC06-434E-9C86-7934E35AF5EF
P2860
A chondroitinase-ABC and TGF-β1 treatment regimen for enhancing the mechanical properties of tissue-engineered fibrocartilage.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A chondroitinase-ABC and TGF-β ...... sue-engineered fibrocartilage.
@en
type
label
A chondroitinase-ABC and TGF-β ...... sue-engineered fibrocartilage.
@en
prefLabel
A chondroitinase-ABC and TGF-β ...... sue-engineered fibrocartilage.
@en
P2093
P2860
P1433
P1476
A chondroitinase-ABC and TGF-β ...... sue-engineered fibrocartilage.
@en
P2093
Eleftherios A Makris
Kyriacos A Athanasiou
Regina F MacBarb
P2860
P304
P356
10.1016/J.ACTBIO.2012.09.037
P50
P577
2012-10-04T00:00:00Z